CT
GSK icon

Clearstead Trust’s GSK GSK Stock Holding History

Clearstead Trust’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.4K Hold
1,304
– – 0.01% 291
2026
Q1 		$72K Sell
1,304
-124
-9% -$6.72K 0.01% 274
2025
Q4 		$70K Buy
1,428
+12
+0.8% +$560 0.01% 294
2025
Q3 		$61.1K Sell
1,416
-111
-7% -$4.34K 0.01% 294
2025
Q2 		$58.6K Buy
1,527
+138
+10% +$5.27K 0.01% 296
2025
Q1 		$53.8K Buy
1,389
+213
+18% +$7.8K 0.01% 266
2024
Q4 		$39.8K Buy
1,176
+12
+1% +$432 0.01% 272
2024
Q3 		$47.6K Buy
1,164
+11
+1% +$450 0.01% 246
2024
Q2 		$44.4K Buy
1,153
+11
+1% +$463 0.01% 245
2024
Q1 		$49K Buy
1,142
+10
+0.9% +$412 0.01% 244
2023
Q4 		$42K Buy
1,132
+10
+0.9% +$359 0.01% 245
2023
Q3 		$40.7K Buy
1,122
+11
+1% +$390 0.01% 234
2023
Q2 		$39.6K Buy
1,111
+10
+0.9% +$359 0.01% 222
2023
Q1 		$39.2K Buy
1,101
+10
+0.9% +$350 0.01% 225
2022
Q4 		$38K Buy
1,091
+13
+1% +$433 0.01% 242
2022
Q3 		$32K Buy
+1,078
New +$40.9K 0.01% 230

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Clearstead Trust's GSK Position: Q2 2026 in Review

Clearstead Trust held its GSK (GSK) position steady in Q2 2026 at 1,304 shares worth $68.4K. The position accounts for 0.01% of the portfolio, ranked #291.

Clearstead Trust first reported a position in GSK in Q3 2022 and has held it in 16 quarters since. The position peaked at $72K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Clearstead Trust held 1,304 shares of GSK worth $68.4K as of Q2 2026.
  • Clearstead Trust left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.01% of Clearstead Trust's portfolio in Q2 2026, its #291 holding.
  • Clearstead Trust first reported a position in GSK in Q3 2022 and has held it in 16 quarters since.
  • Clearstead Trust's GSK position peaked at $72K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.